DavidJacobErleMD
Pulmonology • San Francisco, CACritical Care Medicine, Pleural Disease
Professor, Medicine, UCSF School of Medicine
Are you Dr. Erle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Ave
Rm 3k1
San Francisco, CA 94110Phone+1 415-206-8314Fax+1 415-695-1551
Summary
- Dr. David Erle, MD is a pulmonologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center and is a Professor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996- University of California (San Francisco)Residency, Internal Medicine, 1984 - 1986
- University of California San Francisco School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 174 citationsA tissue checkpoint regulates type 2 immunitySteven J. Van Dyken, Jesse C. Nussbaum, Jinwoo Lee, Ari B. Molofsky, Hong-Erh Liang
Nature Immunology. 2016-12-01 - 195 citationsSquamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patientsJun Araya, Stephanie Cambier, Jennifer A. Markovics, Paul J. Wolters, David M. Jablons
The Journal of Clinical Investigation. 2007-11-01 - 73 citationsSelective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway DiseaseShunsuke Minagawa, Jianlong Lou, Robert Seed, Anthony Cormier, Shenping Wu
Science Translational Medicine. 2014-06-18
Press Mentions
Special Notice Concerning COVID-19February 17th, 2021
‘ImmunoX’ Initiative a Radical Collaboration Across UCSFSeptember 14th, 2018- UCSF Launches Process to Reimagine Parnassus Heights CampusMarch 19th, 2018
Grant Support
- Micro-Rnas In Airway Epithelial Differentiation And AsthmaNational Heart, Lung, And Blood Institute2011–2012
- Specialized Molecules With Essential Roles In Mucus ProductionNational Heart, Lung, And Blood Institute2010–2012
- Airway Epithelial Responses To Allergic InflammationNational Heart, Lung, And Blood Institute2006–2010
- Tools For High-Throughput Functional Analysis Of 3'UTR Cis-Regulatory ElementsNational Human Genome Research Institute2008–2009
- Shared Microarray FacilityNational Heart, Lung, And Blood Institute2002–2005
- Role Of Leukocyte Integrins In Airway Inflammation And HyperresponsivenessNational Heart, Lung, And Blood Institute1997–2005
- Integrin Alpha 4 Beta 7 And Regulation Of Gut ImmunityNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Chemokines As Regulators Of Leukocyte Integrin ActivityNational Heart, Lung, And Blood Institute1999–2003
- Role Of Novel Adhesion Receptor Of Lung LeukocytesNational Heart, Lung, And Blood Institute1995–1997
- Role Of Leukocyte Integrins In Airway Inflammation And HyperresponsivenessNational Heart, Lung, And Blood Institute1996
- Molecular Basis Of Lymphocyte Recruitment To The LungNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1996
- Characterization Of A Novel Lymphocyte Integrin Alpha SubunitNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994
- Novel Adhesion Receptor On Lung LeukocytesNational Heart, Lung, And Blood Institute1994
